Substandard Generic Drugs — Threats to Patient Safety and National Security
New England Journal of Medicine · 30.04.2026 · 394 (17) · 1669-1672
DOI: 10.1056/nejmp2518256 ↗Kurz gefasst
Fachartikel in der Zeitschrift New England Journal of Medicine, erschienen am 30.04.2026. Verfasst von Kevin Schulman und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hospital Medicine, School of Medicine, Stanford University, Stanford, CA. Die Arbeit nennt 5 Literaturangaben.
Themen: Patientensicherheit
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Division of Hospital Medicine, School of Medicine, Stanford University, Stanford, CA.
- Operations, Information, and Technology, Graduate School of Business, Stanford University, Stanford, CA.
- Department of Emergency Medicine, School of Medicine, Emory University, Atlanta.
ORCID-Profile: Kevin Schulman
Zitieren
APA
Schulman, K., & Kellermann, A. L. (2026). Substandard Generic Drugs — Threats to Patient Safety and National Security. New England Journal of Medicine, 394(17), 1669-1672. https://doi.org/10.1056/nejmp2518256
Vancouver
Schulman K, Kellermann AL. Substandard Generic Drugs — Threats to Patient Safety and National Security. New England Journal of Medicine. 2026;394(17):1669-1672. doi:10.1056/nejmp2518256
BibTeX
@article{Schulman2026,
author = {Schulman, Kevin and Kellermann, Arthur L},
title = {Substandard Generic Drugs — Threats to Patient Safety and National Security},
journal = {New England Journal of Medicine},
year = {2026},
volume = {394},
number = {17},
pages = {1669--1672},
doi = {10.1056/nejmp2518256}
}
EUVIMED